Status:
COMPLETED
Probiotics Against Pathogenic Bacteria in Connection With Anaesthesia
Lead Sponsor:
Region Skane
Collaborating Sponsors:
Lund University
Conditions:
Oropharyngeal Microbiology
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Longer surgical procedures require intubation and there is a potential risk of contaminating the lower airways with pathogenic bacteria from the mouth and oropharynx. Healthy people seldom have patho...
Eligibility Criteria
Inclusion
- Adult patients
- Planned interventions
- Anaesthesia \> 4 hours and requiring intubation
Exclusion
- Ulcers in the mouth, oropharynx, oesophagus and stomach
- Current infections in the airways
- Known immuno deficiences
- Emergency cases
Key Trial Info
Start Date :
January 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2020
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT01521650
Start Date
January 1 2012
End Date
July 1 2020
Last Update
March 10 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lund University Hospital
Lund, Sweden, SE-22185